Pharmafile Logo

Resonant Group’s CEO celebrated for driving innovation and professional excellence across the healthcare communications sector

October 9, 2025 | Resonant Group 

Resonant Group’s CEO celebrated for driving innovation and professional excellence across the healthcare communications sector

- PMLiVE

London, 8 October 2025. David Youds, CEO of Resonant Group, has been recognised by Lloyds Development Capital (LDC) as One to Watch in their Top 50 Most Ambitious Business Leaders for 2025, which recognises the UK’s most driven and high-performing entrepreneurs. The list was published today in The Times.

Resonant Group has become one of the UK’s leading independent healthcare communications consultancies. It is an award-winning communications group home to Bedrock (medical communications), Anthem (PR) and Origins (patient strategy consultancy). Together, they support global pharma and biotech clients to better engage audiences with health communications that improve and save lives.

Under David’s leadership, Resonant has become the fastest growing healthcare communications consultancy in the UK, achieving 28% growth in revenue to £6.8 million, and is the 12th fastest growing in the entire UK PR industry, according to PRWeek’s Top 150 2025 league tables.

This recognition reflects the Group’s focus on insight-led and strategic communications, strong client partnerships, and innovative approaches that deliver life-changing impact.

Quote from David Youds, CEO, Resonant Group

“This recognition comes at a time when the trading landscape has been tough, especially in healthcare communications. Economic pressures have made growth harder to achieve. Our success is the result of our great people living to our values and staying true to delivering insight-led and strategic communications. It’s a testament to the extraordinary work of the team and the trust our clients place in us.”

This latest achievement follows a series of award wins for the Group, including Bedrock being named Communiqué Medical Affairs Agency of the Year 2025.

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

When it’s OK to not be OK: Bedrock breaks down mental health stigma

As part of Bedrock’s Wellbeing Programme, Bedrock paired up with Simpila to talk about mental health challenges and open up about the pressures we all face, both in and out...

Bedrock creates waves

The Bedrock team were awash with ideas at their summer watersports and BBQ event. All were Bravely Bedrock in a host of activities – including wakeboarding, paddle boarding and taming...

Bedrock LEAPs to new heights

What do our future leaders say about LEAP?

Bedrock Group strengthens its senior team

Bedrock strengthen its management team with the recruitment of two senior roles

A postcard from Cannes

This week sees the annual Cannes Lions International Festival of Creativity, bringing together leading creative talent from across the globe to learn, share and inspire each other. Until recently, pharmaceuticals...

A variety of backgrounds, a unified purpose

How did Bedrock become Bedrock? We asked members of the Bedrock team how they found their way into the (somewhat hidden) world of medical communications, and what they love about...

Wanda Lesowiec did it. Could you?

How a background in pharma can mean a bright future in medical communications

Am I wrong to be apprehensive about gene therapy?

Is the introduction of gene therapy going to be smooth sailing? Origin's Strategic Solutions Director, Su Smith, shares her thoughts.

Bedrock Group announces the launch of Origins, a health experience research company

Bedrock Group is proud to announce the launch of Origins, a health experience research company.

Artificial Intelligence: a new character in the storytelling of drug development and discovery?

Written by Edward Jones, Junior Medical Writer. Bedrock is dedicated to creating valuable and powerful stories to engage audiences that drive an improvement in the provision of health. This focus...